Essure birth control was first approved in 2002. — -- U.S. regulators said they would review a popular birth control implant device at a panel this week following multiple complaints. The implant ...

WASHINGTON, D.C. (WPVI) -- A local congressman says the FDA grossly underestimated the harm caused by a contraceptive device. And he alleges the maker paid doctors kickbacks to recommend the device to ...

WASHINGTON (AP) — Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression ...

A growing number of women are raising concerns about a form of birth control developed in the Bay Area. Some are demanding it be pulled from the market, despite reassurances from both the manufacturer ...

PHILADELPHIA (WPVI) -- The FDA slapped new restrictions on the sale of a controversial birth control device on Monday. The agency said some women aren't being properly informed of the risks of Essure ...

A measure that would require landlords to accept third party rent is moving forward. The proposed bill just passed the Senate floor. Lawmakers say many tenants get help from family members or ...

At the request of the Food and Drug Administration, Leverkusen, Germany-based Bayer will now add a box warning and patient decision checklist to the label of its permanent birth control device Essure.

Bayer AG on Wednesday urged Illinois' top court to dismiss claims by 160 out-of-state women who claim it failed to warn of the dangers associated with its Essure birth control device, saying the cases ...

WASHINGTON — Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, bleeding and ...

NEW YORK (CBS.MW) -- Shares of Conceptus gained 21 percent to $12.73 after it obtained a category 1 CPT code for its Essure birth control procedure from the American Medical Association, which could ...

NEW YORK, July 20 (Reuters) - Healthcare company Bayer on Friday said it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the ...

Bayer said in 2018 that it would end sales of the Essure birth control product in the U.S., citing declining sales of the implantable device and not based on safety concerns. Bayer said Thursday it ...